SCHEMBL11059378

SCHEMBL11059378

O=C(Nc1ccccc1)Nc1ccc(NC(=O)Nc2ccccc2)cc1

nearest known ligand 0.94

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.94
▸ TP53 P04637 1/20 0.94
▸ EPHX1 P07099 1/20 0.94
▸ TSHR P16473 1/20 0.94
▸ EPHX2 P34913 1/20 0.94
▸ CDK9 P50750 1/20 0.94
▸ CLK4 Q9HAZ1 1/20 0.94
▸ CASP3 P42574 1/20 0.86
▸ SENP7 Q9BQF6 1/20 0.86
▸ MAOA P21397 2/20 0.82
▸ MAOB P27338 2/20 0.82
▸ KMT2A Q03164 8/20 0.78
▸ RAB9A P51151 7/20 0.78
▸ NPC1 O15118 6/20 0.78
▸ TAAR1 Q96RJ0 3/20 0.78
▸ SIRT1 Q96EB6 1/20 0.75
▸ MAPT P10636 4/20 0.72
▸ CA12 O43570 1/20 0.67
▸ CA1 P00915 1/20 0.67
▸ CA2 P00918 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diphenylurea SCHEMBL133103 0.97 SMN1; SMN2 (1.00) SMN1; SMN2TP53EPHX1TSHREPHX2
Diphenylurea SCHEMBL29392345 0.94 SMN1; SMN2 (0.94) SMN1; SMN2TP53EPHX1TSHREPHX2
Diphenylurea SCHEMBL30786615 0.94 SMN1; SMN2 (0.94) SMN1; SMN2TP53EPHX1TSHREPHX2
Diphenylurea SCHEMBL28431956 0.94 SMN1; SMN2 (0.94) SMN1; SMN2TP53EPHX1TSHREPHX2
Diphenylurea SCHEMBL3037927 0.94 SMN1; SMN2 (0.94) SMN1; SMN2TP53EPHX1TSHREPHX2
SCHEMBL12010916 0.93 CASP3 (1.00) SMN1; SMN2TP53EPHX1TSHREPHX2
SCHEMBL30051986 0.93 CASP3 (1.00) SMN1; SMN2TP53EPHX1TSHREPHX2
SCHEMBL9479905 0.93 CASP3 (1.00) SMN1; SMN2TP53EPHX1TSHREPHX2
SCHEMBL5705930 0.91 MAOA (1.00) SMN1; SMN2TP53EPHX1TSHREPHX2
SCHEMBL5359926 0.91 SMN1; SMN2 (0.77) SMN1; SMN2TP53EPHX1TSHREPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115536554-B 1,1' - (1, 4-Phenylene) bis (3-phenylurea)/aniline corrosion inhibitor and preparation method and application thereof 青海师范大学 2024-04-26 — — CN claimed
CN-115536554-A 1,1' - (1, 4-phenylene) bis (3-phenylurea)/aniline corrosion inhibitor and preparation method and application thereof 青海师范大学 2022-12-30 — — CN claimed
US-20250241890-A1 1,4-DIUREAS AND 1,4-DITHIOUREAS AND USES THEREOF PURDUE RESEARCH FOUNDATION 2025-07-31 — — US disclosed
CN-115536554-B 1,1' - (1, 4-Phenylene) bis (3-phenylurea)/aniline corrosion inhibitor and preparation method and application thereof 青海师范大学 2024-04-26 — — CN disclosed
CN-115536554-B 1,1' - (1, 4-Phenylene) bis (3-phenylurea)/aniline corrosion inhibitor and preparation method and application thereof 青海师范大学 2024-04-26 — — CN disclosed
CN-115536554-B 1,1' - (1, 4-Phenylene) bis (3-phenylurea)/aniline corrosion inhibitor and preparation method and application thereof 青海师范大学 2024-04-26 — — CN disclosed
CN-115536554-A 1,1' - (1, 4-phenylene) bis (3-phenylurea)/aniline corrosion inhibitor and preparation method and application thereof 青海师范大学 2022-12-30 — — CN disclosed
CN-115536554-A 1,1' - (1, 4-phenylene) bis (3-phenylurea)/aniline corrosion inhibitor and preparation method and application thereof 青海师范大学 2022-12-30 — — CN disclosed
CN-115536554-A 1,1' - (1, 4-phenylene) bis (3-phenylurea)/aniline corrosion inhibitor and preparation method and application thereof 青海师范大学 2022-12-30 — — CN disclosed
CN-113773475-B Catalyst containing bithiophene structure and application thereof in ring-opening polymerization of cyclic ester under light control 安徽大学 2022-06-07 — — CN disclosed
CN-113773475-A Catalyst containing bithiophene structure and application thereof in ring-opening polymerization of cyclic ester under light control 安徽大学 2021-12-10 — — CN disclosed
US-4444863-A UREA COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1984-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250241890-A1 1,4-DIUREAS AND 1,4-DITHIOUREAS AND USES THEREOF SNCA, PARK7, SYNCRIP SMN1; SMN2 14/4885TP53 1480/4885EPHX1 3866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback